Cerebral Aspects of Portal Hypertension: Hepatic Encephalopathy

Clin Liver Dis. 2024 Aug;28(3):541-554. doi: 10.1016/j.cld.2024.03.008. Epub 2024 Apr 27.

Abstract

Portal hypertension has cerebral consequences via its causes and complications, namely hepatic encephalopathy (HE), a common and devastating brain disturbance caused by liver insufficiency and portosystemic shunting. The pathogenesis involves hyperammonemia and systemic inflammation. Symptoms are disturbed personality and reduced attention. HE is minimal or grades I to IV (coma). Bouts of HE are episodic and often recurrent. Initial treatment is of events that precipitated the episode and exclusion of nonhepatic causes. Specific anti-HE treatment is lactulose. By recurrence, rifaximin is add-on. Anti-HE treatment is efficacious also for prophylaxis, but emergence of HE marks advanced liver disease and a dismal prognosis.

Keywords: Cirrhosis; Hepatic encephalopathy; Hyperammonemia; Inflammation; Portal hypertension.

Publication types

  • Review

MeSH terms

  • Gastrointestinal Agents / therapeutic use
  • Hepatic Encephalopathy* / etiology
  • Hepatic Encephalopathy* / physiopathology
  • Humans
  • Hyperammonemia / complications
  • Hyperammonemia / etiology
  • Hypertension, Portal* / complications
  • Hypertension, Portal* / etiology
  • Hypertension, Portal* / physiopathology
  • Lactulose* / therapeutic use
  • Rifaximin / therapeutic use

Substances

  • Lactulose
  • Rifaximin
  • Gastrointestinal Agents